{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:37:48Z","timestamp":1768441068490,"version":"3.49.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Council of Norway, Global Health and Vaccination Research","award":["248042"],"award-info":[{"award-number":["248042"]}]},{"DOI":"10.13039\/501100009527","name":"Statens Serum Institut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009527","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aeras Global Tuberculosis Vaccine Foundation NPC"},{"name":"EDCTP 2 Programme supported by the European Union"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>The prevalence of latent tuberculosis infection (LTBI) is vastly higher than that of tuberculosis (TB) disease and this enormous reservoir of individuals with LTBI impacts the global TB control strategy. Adolescents are at greatest risk of TB infection and are thus an ideal target population for a potential effective TB vaccine to be added to the current BCG programme as it could reduce the number of latent infections and consequently the number of adults with TB disease. However, LTBI rates are often unknown for this population. This study aims to estimate the magnitude of LTBI and to determine if Tanzanian adolescents would be a good population for a prevention of TB infection trial.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>This was a descriptive cross-sectional study that recruited 193 adolescents aged 12 and 16 years from government schools and directly from the community in Mwanza Region, Tanzania. Socio-demographic characteristics were collected for all enrolled participants. Blood was drawn and tested using QuantiFERON-TB Gold In-Tube (QFT-GIT), and Early Secretory Antigenic Target-6\u2013Free Interferon-gamma Release Assay (ESAT-6 free IGRA). Concordance between QFT-GIT and ESAT-6 free IGRA was evaluated using the McNemar\u2019s test.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>Overall estimates of LTBI prevalence were 19.2% [95%CI, 14.1; 25.2] and 18.6% [95%CI, 13.6; 24.6] as measured by QFT-GIT IGRA and ESAT-6 free IGRA, respectively. The 16-year-old cohort had a higher LTBI prevalence (23.7% [95%CI, 16.1; 32.9]) as compared to 12-year-old cohort (14.6% [95%CI, 8.6; 22.7]) as measured by QFT-GIT IGRA. When measured by ESAT-6 Free IGRA, LTBI prevalence was 24.7% (95%CI, 16.9; 34.0) for the 16-year-old cohort and 12.5% (95%CI, 7.0; 20.3) among the 12-year-old cohort. According to both tests the prevalence of TB infection and the corresponding annual risk of tuberculosis infection (ARTI) and force of infection were high and increased with age. Of all enrolled participants, 97.4% had concordant results for QFT-GIT IGRA and ESAT-6 free IGRA (p = 0.65).<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusions<\/jats:title><jats:p>The prevalence of LTBI and the associated ARTI and force of infection among adolescents is high and increases with age in Mwanza Region. There was a high concordance between the QFT-GIT and the novel ESAT-6 free IGRA assays. These findings suggest Mwanza is a promising area to conduct novel TB vaccine research prevention of infection (POI) studies targeting adolescents.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0252808","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T17:27:24Z","timestamp":1623086844000},"page":"e0252808","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7900-9689","authenticated-orcid":true,"given":"Kidola","family":"Jeremiah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Lyimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5095-0624","authenticated-orcid":true,"given":"Christian","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"PrayGod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn Tucker","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Smith","family":"Korsholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Ruhwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dereck","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harleen M. S.","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-0155","authenticated-orcid":true,"given":"Daniel","family":"Faurholt-Jepsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"pone.0252808.ref001","unstructured":"Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO"},{"key":"pone.0252808.ref002","unstructured":"The Stop TB Partnership. 12 months of COVID-19 eliminated 12 years of progress in the global fight against tuberculosis. March 18, 2021. http:\/\/www.stoptb.org\/news\/stories\/2021\/ns21_011.html."},{"key":"pone.0252808.ref003","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"H MA Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0252808.ref004","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.lungcan.2014.07.001","article-title":"Latent TB infection in newly diagnosed lung cancer patients\u2014A multicenter prospective observational study","volume":"85","author":"WC Fan","year":"2014","journal-title":"Lung Cancer"},{"key":"pone.0252808.ref005","first-page":"B223","article-title":"Preventive vaccines for tuberculosis","volume":"18","author":"BM Evans TG","year":"2013","journal-title":"Vaccine"},{"key":"pone.0252808.ref006","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijbiomac.2018.08.037","article-title":"Novel vaccine candidates against Mycobacterium tuberculosis","volume":"120","author":"S Khoshnood","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"pone.0252808.ref007","first-page":"S146","article-title":"Tuberculosis 2000\u20132010: control, but not elimination","volume":"4","author":"C WB Dye","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0252808.ref008","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"(2008) Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"WB Dye C","year":"2008","journal-title":"J R Soc Interface"},{"key":"pone.0252808.ref009","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"LJ SL Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0252808.ref010","first-page":"406","article-title":"Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa","volume":"14","author":"R Wood","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0252808.ref011","doi-asserted-by":"crossref","first-page":"e59652","DOI":"10.1371\/journal.pone.0059652","article-title":"TB incidence in an adolescent cohort in South Africa","volume":"8","author":"H Mahomed","year":"2013","journal-title":"PLoS One"},{"key":"pone.0252808.ref012","first-page":"331","article-title":"Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa","volume":"15","author":"H Mahomed","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0252808.ref013","doi-asserted-by":"crossref","first-page":"e17984","DOI":"10.1371\/journal.pone.0017984","article-title":"The tuberculin skin test versus QuantiFERON TB Gold(R) in predicting tuberculosis disease in an adolescent cohort study in South Africa","volume":"6","author":"H Mahomed","year":"2011","journal-title":"PLoS One"},{"key":"pone.0252808.ref014","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1164\/rccm.201206-1134OC","article-title":"Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents","volume":"186","author":"S VS Machingaidze","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0252808.ref015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tube.2015.02.036","article-title":"Innovative clinical trial designs to rationalize TB vaccine development","volume":"95","author":"RD Ellis","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"pone.0252808.ref016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"E Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0252808.ref017","unstructured":"The National Tuberculosis and leprosy Programme Annual report for 2017https:\/\/ntlp.go.tz\/site\/assets\/files\/1046\/ntlp_annual_report_2017_final.pdf."},{"key":"pone.0252808.ref018","doi-asserted-by":"crossref","first-page":"e64008","DOI":"10.1371\/journal.pone.0064008","article-title":"The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-\u03b3 release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania","volume":"8","author":"AV JL Jensen","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"pone.0252808.ref019","article-title":"Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities","volume":"205","author":"R MM McNerney","year":"2012","journal-title":"J Infect Dis"},{"key":"pone.0252808.ref020","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"AK Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"pone.0252808.ref021","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1038\/srep45969","article-title":"Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6","volume":"7","author":"M Ruhwald","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0252808.ref022","volume-title":"2012 Census Data","author":"Statistics TNBo","year":"2012"},{"key":"pone.0252808.ref023","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/ciz034","article-title":"Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube","volume":"69","author":"E Nemes","year":"2019","journal-title":"Clin Infect Dis"},{"key":"pone.0252808.ref024","volume-title":"QuantiFERON-TB Gold package insert","author":"Cellestis","year":"2015"},{"key":"pone.0252808.ref025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2334-11-156","article-title":"Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study","volume":"11","author":"BL Middelkoop K","year":"2011","journal-title":"BMC Infect Dis"},{"key":"pone.0252808.ref026","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0252808.ref027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"M Pai","year":"2014","journal-title":"Clinical microbiology reviews"},{"key":"pone.0252808.ref028","first-page":"156","article-title":"Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection","volume":"183","author":"PJ Dodd","year":"2016","journal-title":"Am J Epidemiol"},{"key":"pone.0252808.ref029","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12879-019-4314-7","article-title":"Estimating the annual risk of infection with Mycobacterium tuberculosis among adolescents in Western Kenya in preparation for TB vaccine trials","volume":"19","author":"V Nduba","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pone.0252808.ref030","first-page":"211","article-title":"Mantoux skin test reactivity among household contacts of HIV-infected and HIV un-infected patients with sputum smear positive TB in Dar es Salaam","volume":"6","author":"EJ Kifai","year":"2009","journal-title":"Tanzania. East Afr J Public Health"},{"key":"pone.0252808.ref031","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/tmi.12484","article-title":"Risk of infection and disease with Mycobacterium tuberculosis among children identified through prospective community-based contact screening","volume":"20","author":"R Triasih","year":"2015","journal-title":"Indonesia. Trop Med Int Health"},{"key":"pone.0252808.ref032","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.aids.0000218557.44284.83","article-title":"The impact of the HIV epidemic on tuberculosis transmission in Tanzania","volume":"20","author":"SM Egwaga","year":"2006","journal-title":"AIDS"},{"key":"pone.0252808.ref033","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1183\/09031936.94.07050946","article-title":"Risk of infection and estimated incidence of tuberculosis in northern Uganda","volume":"7","author":"GB Migliori","year":"1994","journal-title":"Eur Respir J"},{"key":"pone.0252808.ref034","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2105\/AJPH.89.7.1078","article-title":"Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986\u20131996","volume":"89","author":"JA Odhiambo","year":"1999","journal-title":"Am J Public Health"},{"key":"pone.0252808.ref035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/589750","article-title":"Rates of Tuberculosis Transmission to Children and Adolescents in a Community with a High Prevalence of HIV Infection among Adults","volume":"47","author":"K Middelkoop","year":"2008","journal-title":"Clinical Infectious Diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T06:20:42Z","timestamp":1672381242000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252808"}},"subtitle":[],"editor":[{"given":"Frederick","family":"Quinn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252808","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}